Products

What will AGI do for Benzquinamide?

This classification denotes an antiemetic agent with the molecular formula C22H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0475EA27Q3, chemically known as 3-diethylcarbamoyl-2,3,4,6,7,11b-hexahydro-9,10-dimethoxy-1h-benzo(a)chinolizin-2-yl acetat but generally known as benzquinamide, which bears US NIH Compound Identifier 2342. Benzquinamide most often comes in base and hydrochloride forms. European Medicines Agency schedules Benzquinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05768MIG. The term BENZQUINAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). BENZQUINAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzquinamide under HS 29339990 and SITC 51577. As of Q4 2014, BENZQUINAMIDE remains the US FDA Preferred Term for this commodity. Benzquinamide bears US NLM identifiers UMLS ID C0053284 and NCI Concept Code C65253. SMILES: O(C1C(CN2C(C1)C1C(CC2)CC(OC)C(OC)C1)C(=O)N(CC)CC)C(=O)C.